ArticleNature communications2024

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.

Evanthia Galanis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.